首页> 美国卫生研究院文献>The Journal of Molecular Diagnostics : JMD >Microsatellite Stable Colorectal Cancers in Clinically Suspected Hereditary Nonpolyposis Colorectal Cancer Patients without Vertical Transmission of Disease Are Unlikely to Be Caused by Biallelic Germline Mutations in MYH
【2h】

Microsatellite Stable Colorectal Cancers in Clinically Suspected Hereditary Nonpolyposis Colorectal Cancer Patients without Vertical Transmission of Disease Are Unlikely to Be Caused by Biallelic Germline Mutations in MYH

机译:临床疑似遗传性非息肉病大肠癌患者中无垂直传播疾病的微卫星稳定大肠癌很可能是由MYH中的双等位基因生殖突变引起的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microsatellite analysis and immunohistochemistry are commonly used initial screening tests for hereditary nonpolyposis colorectal cancer. However, tumors in roughly one-half of the patients fulfilling the Bethesda guidelines are microsatellite stable. In addition, normal mismatch repair protein expression in these tumors suggests that a defect in the mismatch repair system is unlikely. Because biallelic MYH mutations occur in patients with both high and low numbers of adenomas, we hypothesized that MYH is involved in the tumorigenesis of microsatellite stable colorectal cancers in patients without vertical transmission of disease and who fulfill the Bethesda guidelines. MYH was analyzed in 50 cancer patients and 116 healthy controls by complete genomic DNA sequencing. No biallelic germline mutations were identified. One patient was a heterozygous carrier for the p.G382D missense mutation, and another patient was a heterozygous carrier for the novel missense mutation p.Q484H. We identified six common variants, three in the coding region (p.V22M, p.Q324H, and p.S501F) and three in adjacent intronic regions (c.157+30A>G, c.462+35G>A, and c.1435–40G>C). In summary, biallelic germline mutations of MYH are unlikely to cause colorectal cancer in patients sharing clinical features with hereditary nonpolyposis colorectal cancer families without mismatch repair defect and therefore cannot fill the molecular diagnostic gap in this subgroup of Bethesda-positive patients.
机译:微卫星分析和免疫组织化学是遗传性非息肉病性结直肠癌的常用初步筛选测试。但是,在符合Bethesda指南的患者中,约有一半的肿瘤是微卫星稳定的。另外,在这些肿瘤中正常的失配修复蛋白表达表明失配修复系统中的缺陷是不可能的。因为双等位基因MYH突变发生在腺瘤数目高和低的患者中,所以我们假设MYH参与了无垂直疾病传播且符合Bethesda指南的患者的微卫星稳定结直肠癌的肿瘤发生。通过完整的基因组DNA测序对50例癌症患者和116个健康对照者的MYH进行了分析。没有鉴定出双等位基因种系突变。一名患者是p.G382D错义突变的杂合子携带者,另一名患者是新的错义突变p.Q484H的杂合子携带者。我们确定了六个常见变体,三个在编码区域(p.V22M,p.Q324H和p.S501F),三个在邻近的内含子区域(c.157 + 30A> G,c.462 + 35G> A和c .1435–40G> C)。总之,MYH的双等位基因种系突变不太可能导致具有遗传性非息肉病结直肠癌家族且无错配修复缺陷的临床特征的患者出现结直肠癌,因此无法填补贝塞斯达阳性患者这一亚组的分子诊断空白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号